Aconite-isolated moxibustion at Yongquan(KI 1) combined with rivaroxaban for lower extremity venous thrombosis after total knee arthroplasty: a randomized controlled trial
|更新时间:2023-05-10
|
Aconite-isolated moxibustion at Yongquan(KI 1) combined with rivaroxaban for lower extremity venous thrombosis after total knee arthroplasty: a randomized controlled trial
Chinese Acupuncture and MoxibustionVol. 43, Issue 2, Pages: 144-148(2023)
Aconite-isolated moxibustion at Yongquan(KI 1) combined with rivaroxaban for lower extremity venous thrombosis after total knee arthroplasty: a randomized controlled trial[J]. Chinese Acupuncture and Moxibustion, 2023, 43(2): 144-148.
DOI:
Aconite-isolated moxibustion at Yongquan(KI 1) combined with rivaroxaban for lower extremity venous thrombosis after total knee arthroplasty: a randomized controlled trial[J]. Chinese Acupuncture and Moxibustion, 2023, 43(2): 144-148.DOI: 10.13703/j.0255-2930.20220327-0004.
Aconite-isolated moxibustion at Yongquan(KI 1) combined with rivaroxaban for lower extremity venous thrombosis after total knee arthroplasty: a randomized controlled trial
Objective To investigate the clinical effect of aconite-isolated moxibustion at Yongquan(KI 1) combined with rivaroxaban for lower extremity venous thrombosis after total knee arthroplasty and the influence on hypercoagulation.Methods Seventy-three patients of knee osteoarthritis with lower extremity venous thrombosis after total knee arthroplasty(KOA) were randomly divided into an observation group(37 cases
2 cases dropped off) and a control group(36 cases
1 case dropped off). The patients in the control group took orally rivaroxaban tablets
10 mg a time
once a day. On the basis of the treatment as the control group
the aconite-isolated moxibustion was applied to Yongquan(KI 1) for the patients of the observation group
once daily and 3 moxa cones were used in each treatment. The duration of treatment was 14 days in both groups. Before treatment and 14 days into treatment
the ultrasonic B test was adopted to determine the conditions of lower extremity venous thrombosis in the two groups. Before treatment
7 and 14 days into treatment
the coagulation indexes(platelet [PLT]
prothrombin time [PT]
activated partial prothrombin time [APTT]
fibrinogen [Fib] and D-dimer[D-D])
the blood flow velocity of the deep femoral vein and the circumference of the affected side were compared between the two groups separately
and the clinical effect was evaluated. Results Fourteen days into treatment
the venous thrombosis of the lower extremity was relieved in both groups(P<0.05)
and that of the observation group was better than the control group(P<0.05).Seven days into treatment
the blood flow velocity of the deep femoral vein was increased compared with that before treatment in the observation group(P<0.05)
and the blood flow rate in the observation group was higher than that in the control group(P<0.05). Fourteen days into treatment
PT
APTT and the blood flow velocity of the deep femoral vein were increased in the two groups compared with those before treatment(P<0.05); and PLT
Fib
D-D and the circumference of the limb(knee joint
10 cm above the patella and 10 cm below the patella) were all reduced in the two groups(P<0.05). Compared with the control group 14 days into treatment
the blood flow velocity of the deep femoral vein was higher(P<0.05)
PLT
Fib
D-D and the circumference of the limb(knee joint
10 cm above the patella and 10 cm below the patella) were all lower in the observation group(P<0.05). The total effective rate was 97.1%(34/35) in the observation group
higher than 85.7%(30/35) in the control group(P<0.05). Conclusion Aconite-isolated moxibustion at Yongquan(KI 1) combined with rivaroxaban can effectively treat lower extremity venous thrombosis after total knee arthroplasty
relieve hypercoagulation
accelerate the blood flow velocity and alleviate swelling of the lower extremity in the patients with knee osteoarthritis.